Clinical Trials Directory

Trials / Unknown

UnknownNCT04606082

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI

Intra Uterine Injection of Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor at Ovum Pick up Day Significantly Increase Implantation Rate and Pregnancy Rate in Intra Cytoplasmic Sperm Injection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Al-Azhar University · Academic / Other
Sex
Female
Age
30 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Intrauterine Granulocyte colony stimulating factor (GCSF) was compared with intrauterine Human Chorionic Gonadotropin (HCG) in increasing clinical pregnancy rate as a primary outcome and ultrasound imaging of gestational sac as a secondary outcome.

Detailed description

Two hundred females with history of recurrent implantation failure and undergoing Intracytoplasmic Sprem injection (ICSI) were randomized into two groups; the first group (100 patients) received intrauterine Granulocyte colony stimulating factor (GCSF) and the second group (100) received intrauterine Human Chorionic Gonadotropin (HCG) at ovum pick up day. The clinical pregnancy rate was evaluated as a primary outcome after 14 days and ultrasound imaging of gestational sac was evaluated as a secondary outcome after 6 weeks.

Conditions

Interventions

TypeNameDescription
DRUGGranulocyte Colony Stimulated FactorGCSF was intrauterine injected once at ovum pick up day
DRUGHuman Chorionic Gonadotropins500 IU of HCG was injected intrauterine once at ovum pick up day

Timeline

Start date
2020-10-30
Primary completion
2021-01-10
Completion
2021-01-10
First posted
2020-10-28
Last updated
2020-10-28

Source: ClinicalTrials.gov record NCT04606082. Inclusion in this directory is not an endorsement.

Human Chorionic Gonadotropin Versus Granulocyte Colony Stimulating Factor in Increasing Pregnancy Rate in ICSI (NCT04606082) · Clinical Trials Directory